TowerBrook Capital Partners L.P. in connection with R1 RCM’s $4.1 billion all-stock acquisition of Cloudmed

On January 10, 2022, R1 RCM announced that it has entered into a definitive agreement to acquire Cloudmed in an all-stock transaction. The transaction values Cloudmed at $4.1 billion, including $857 million of net debt.  Wachtell, Lipton, Rosen & Katz served as legal counsel to TowerBrook Capital Partners L.P., R1’s largest shareholder.

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.